Introduction. The aim of this study was to compare the diagnostic value of
two imunoglobulin E assays for penicillin in a group of patients with a
history compatible with hypersensitivity reaction during penicillin treatment
who exhibited positive skin testing and/or a drug provocation testing.
Material and Methods. In the first part of the study, penicillin G, V and/or
amoxicillin specific immunoglobulin E, positive with ImmunoCAP system (Termo
Fisher, Waltham, Massachusetts, USA), were selected from our biobank sera,
and measured specific immunoglobulin E with Immulite system (Siemens, Munich,
Germany). The second part of the study included skin testing, and if
negative, drug provocation testing was done with the culprit penicillin in
patients with a history compatible with hyper?sensitivity reaction during
penicillin treatment. To check the impact of high values of total
immunoglobulin E on performance of specific immunoglobulin E, we examined the
specific immunoglobulin E to penicillin using both methods in sera of
penicillin tolerant patients with total immunoglobulin E over 700 kIU/L.
Results. Out of 2.521 in vitro specific immunoglobulin E penicillin tests, 58
were positive with ImmunoCAP. Of these tests, 52 were tested by the Immulite
and they were all negative. Among 114 patients with a history compatible with
hypersensitivity reac?tion during penicillin treatment, hypersensitivity was
confirmed in 36 (31.6%). In 11 patients with positive immediate skin or drug
provocation tests, ImmunoCAP was positive in 3 patients and Immulite in 1
patient. Sensitivity of ImmunoCAP and Immulite were 27.1% and 9.1%,
respec?tively. Specificity of ImmunoCAP and Immulite were 96.1% and 100%,
respectively. Specific immunoglobulin E to penicillins was detected with
ImmunoCAP in 8/22 sera with total immunoglobulin E over 700 kIU/L. All sera
were negative by the Immulite. Conclusion. Both the Immuno?CAP and Immulite
specific immunoglobulin E assays have low sensitiv?ity when assessing
patients with a history of immediate hypersensitivity to penicillin, positive
immediate skin, or drug provocation tests.